Alk-Abello AS (WBO:ALKB) Valuation Rank


WBO:ALKB Alk-Abello AS WBO:ALKB
66 GF Score
Price €34.22
GF Value €27.26
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Alk-Abello AS Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Alk-Abello AS Valuation Rank Related Terms

WBO:ALKB
66GF Score
Alk-Abello AS WBO:ALKB
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Alk-Abello AS (WBO:ALKB) Overvalued in 2026?

Based on GuruFocus' analysis, Alk-Abello AS stock appears to be overvalued. The current stock price of €34.22 is trading 25.5% above its estimated GF Value™ of €27.26. GuruFocus considers Alk-Abello AS to be Modestly Overvalued.

Key valuation signals for WBO:ALKB:

  • Valuation Rank:
  • GF Value™: €27.26 vs. price of €34.22 (25.5% above fair value)
  • GF Score™: 66/100 with 5 warning signs

No single metric tells the full story. See the WBO:ALKB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Alk-Abello AS Business Description

Address Boge Alle 6-8, Horsholm, DNK, DK-2970
Alk-Abello AS is a biotechnology company that focuses on pharmaceutical prevention, diagnosis, and treatment of allergies. The company is focused on respiratory diseases, including allergic rhinitis and allergic asthma. Moreover, the firm specializes in venom immunotherapy for patients suffering from bee and wasp allergies. The company's treatments induce a protective immune response that provides sustained symptom relief. Its primary focus is on allergy patients whose disease is not well controlled, despite the use of symptom-relieving medication. The company operates in Europe, North America and International Markets. It derives maximum revenue from Europe.
66GF Score

Get the complete analysis for WBO:ALKB

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€34.22
Price
€27.26
GF Value